Results 131 to 140 of about 11,693 (207)
γ-Secretase modulator resistance of an aggressive Alzheimer-causing presenilin mutant can be overcome in the heterozygous patient state by a set of advanced compounds. [PDF]
Alzheimers Res TherTrambauer J, Sarmiento RMR, Garringer HJ, Salbaum K, Pedro LD, Crusius D, Vidal R, Ghetti B, Paquet D, Baumann K, Lindemann L, Steiner H. +11 moreeuropepmc +1 more sourceTPC2 rescues lysosomal storage in mucolipidosis type IV, Niemann-Pick type C1, and Batten disease. [PDF]
EMBO Mol Med, 2022 Scotto Rosato A, Krogsaeter EK, Jaślan D, Abrahamian C, Montefusco S, Soldati C, Spix B, Pizzo MT, Grieco G, Böck J, Wyatt A, Wünkhaus D, Passon M, Stieglitz M, Keller M, Hermey G, Markmann S, Gruber-Schoffnegger D, Cotman S, Johannes L, Crusius D, Boehm U, Wahl-Schott C, Biel M, Bracher F, De Leonibus E, Polishchuk E, Medina DL, Paquet D, Grimm C. +29 moreeuropepmc +1 more sourceA fully iPS-cell-derived 3D model of the human blood-brain barrier for exploring neurovascular disease mechanisms and therapeutic interventions. [PDF]
Nat NeurosciGonzález-Gallego J, Todorov-Völgyi K, Müller SA, Antesberger S, Todorov MI, Malik R, Grimalt-Mirada R, Gonçalves CC, Schifferer M, Kislinger G, Weisheit I, Lindner B, Crusius D, Kroeger J, Borri M, Erturk A, Nelson M, Misgeld T, Lichtenthaler SF, Dichgans M, Paquet D. +20 moreeuropepmc +1 more sourceManagement of high-risk acute pulmonary embolism: an emulated target trial analysis. [PDF]
Intensive Care MedStadlbauer A, Verbelen T, Binzenhöfer L, Goslar T, Supady A, Spieth PM, Noc M, Verstraete A, Hoffmann S, Schomaker M, Höpler J, Kraft M, Tautz E, Hoyer D, Tongers J, Haertel F, El-Essawi A, Salem M, Rangel RH, Hullermann C, Kriz M, Schrage B, Moisés J, Sabate M, Pappalardo F, Crusius L, Mangner N, Adler C, Tichelbäcker T, Skurk C, Jung C, Kufner S, Graf T, Scherer C, Villegas Sierra L, Billig H, Majunke N, Speidl WS, Zilberszac R, Chiscano-Camón L, Uribarri A, Riera J, Roncon-Albuquerque R, Terauda E, Erglis A, Tavazzi G, Zeymer U, Knorr M, Kilo J, Möbius-Winkler S, Schwinger RHG, Frank D, Borst O, Häberle H, De Roeck F, Vrints C, Schmid C, Nickenig G, Hagl C, Massberg S, Schäfer A, Westermann D, Zimmer S, Combes A, Camboni D, Thiele H, Lüsebrink E, High-risk P. E. Investigator Group. +67 moreeuropepmc +1 more sourcePost-mortem multiple sclerosis lesion pathology is influenced by single nucleotide polymorphisms. [PDF]
Brain Pathol, 2020 Fransen NL, Crusius JBA, Smolders J, Mizee MR, van Eden CG, Luchetti S, Remmerswaal EBM, Hamann J, Mason MRJ, Huitinga I. +9 moreeuropepmc +1 more source
